中文版EORTC QLQ-HCC18生命质量评价工具在PHC患者中应用的信效度评价.pdf,2542 重庆 医学 2016年 671第 45卷第 l8期 Hartmann组及单纯造瘘组 (P0.05)。不过在术后第 3天, nalysisEJ].ObstetGynecol,2014,124(3):535—541. 随肠梗阻解 除及肠 内容物 的排 出,3组 的
目的:对中文版原发性肝癌(PHC)患者生命质量量表(EORTCQLQ〩CC18)的信效度进行评价,探索其在国内PHC患者中的适用性.方法征得欧洲癌症研究与治疗组织(EORTC)同意获得中文版EORTCQLQ〩CC18,应用于三级甲等医院的186例PHC患者进行信效度检验.结果中文版EORTCQLQ〩CC18量表共有18个条目,8个维度,总的Cronba... 查看全...
The QLQ-HCC18 fatigue domain achieved acceptable concurrent validity for 13 of 16 correlations; the index domain achieved acceptable concurrent validity for 15 of 16 correlations. Clear differentiation of the QLQ-HCC18 change scores between improvement and maintenance anchor groups were observed for ...
[摘要] 目的 对中文版原发性肝癌(PHC)患者生命质量量表(EORTC QLQ-HCC18)的信效度进行评价,探索其在国内PHC患者中的适用性。方法 征得欧洲癌症研究与治疗组织(EORTC)同意获得中文版EORTC QLQ-HCC18,应用于三级甲等医院的186例PHC患者进行信效度检验。结果 中文版EORTC QLQ-HCC18量表共有18个条目,8个维度,总的...
摘要: 目的:对中文版原发性肝癌(PHC)患者生命质量量表(EORTCQLQ‐HCC18)的信效度进行评价,探索其在国内PHC患者中的适用性。方法征得欧洲癌症研究与治疗组织(EORTC)同意获得中文版EORTCQLQ‐HCC18,应用于三级甲等医院的186例PHC患者进行信效度检验。结果中文版EORTCQLQ‐HCC18量表共... 查看全部>> ...
This study aimed to develop and validate the Simplified Chinese Version of the Quality of Life Questionnaire for Hepatocellular Carcinoma (the QLQ-HCC18). It was developed by the strict translation procedure of EORTC guidelines, and the psychometrics were evaluated on a sample of 114 patients. The...
for sorafenib-treated patients with advanced HCC): 13.9 vs. 10.6 months (HR 0.77, 95% CI, 0.62–0.96,p = 0.0112) [17]. The PFS was also maintained: 3.3 vs. 2.8 months (HR 0.70, 95% CI, 0.56–0.89,p = 0.0011) with a superior RR (18.3% vs. 4.4% with placebo) [18]...
MWPC point estimates defining improvement for the QLQ-HCC18 fatigue and index domains were 7.18 and 4.07, respectively; MWPC point estimates defining deterioration were 5.34 and 3.16, respectively. The EORTC QLQ-HCC18 fatigue and index domains consistently demonstrated robust psychometric properties, ...
International cross-cultural field validation of an EORTC questionnaire module for patients with primary liver cancer, the EORTC QLQ-HCC18Chie, W CBlazeby, J MHsiao, C FChiu, H CPoon, R TMikoshiba, NAlKadhimi, GHeaton, NCalara, J...
Health-related quality-of-life (HRQOL) assessment with EORTC QLQ-C30 was prognostic for overall survival (OS) in patients with advance-stage hepatocellular carcinoma (HCC), but no data existed for early-stage patients. The HCC-specific QLQ-HCC18 has not been evaluated for prognostic value in ...